Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3002079	du-na	mmol/24h (mmol/24h)	1962	2437	0.29%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malaise and fatigue

7.22

8.19

1.4

1.0

143.70

138.85

mmol/24h

0.11

Symptoms and signs involving the nervous and musculoskeletal systems

4.54

4.29

1.0

125.20

142.13

mmol/24h

—

Any mental disorder

3.22

4.01

1.1

140.05

144.33

mmol/24h

0.10

Hypothyroidism (congenital or acquired)

6.39

3.89

1.4

1.0

129.71

124.86

mmol/24h

—

Other antidepressants

3.06

3.59

1.1

148.29

139.66

mmol/24h

0.22

Psychiatric diseases

3.04

3.51

1.1

141.41

144.33

mmol/24h

0.07

Recurrent or chronic depression

5.42

3.37

1.1

1.2

151.57

127.88

mmol/24h

—

Depression or dysthymia

4.30

3.33

1.1

1.2

146.52

147.33

mmol/24h

—

Other menopausal disorders

8.07

3.21

1.1

1.2

133.67

90.00

mmol/24h

—

Persons encountering health services in circumstances related to reproduction

3.55

3.13

1.2

131.86

145.22

mmol/24h

0.37

Antihypertensive medication - note that there are other indications

3.23

3.04

1.3

1.0

137.64

132.49

mmol/24h

0.13

Hypothyroidism and >3 levothyroxin purchases

5.11

2.80

1.1

1.0

117.17

124.86

mmol/24h

—

Hypothyroidism, levothyroxine purchases

5.11

2.80

1.1

1.0

117.17

124.86

mmol/24h

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.85

2.72

1.1

1.0

125.69

150.39

mmol/24h

0.93

General symptoms and signs

2.68

2.58

1.1

1.0

139.84

136.83

mmol/24h

0.08

Other headache syndromes

3.46

2.48

1.0

146.93

137.52

mmol/24h

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.68

2.43

1.3

1.0

137.22

139.70

mmol/24h

0.06

Preterm labour and delivery

5.00

2.40

1.0

1.1

126.61

134.61

mmol/24h

—

Genitourinary diseases

3.34

2.39

1.1

1.3

131.13

158.55

mmol/24h

—

Other symptoms and signs involving cognitive functions and awareness

4.69

2.27

1.2

1.0

129.63

130.07

mmol/24h

—

Disorders of the thyroid gland

2.57

2.26

1.3

1.0

138.84

139.72

mmol/24h

0.02

Finngen Rheumatological endpoints

2.42

2.10

1.0

1.1

139.22

144.22

mmol/24h

0.12

Hypothyroidism, strict autoimmune

2.70

2.09

1.4

1.0

143.79

139.42

mmol/24h

0.11

Hypothyroidism, other/unspecified

2.55

2.08

1.3

1.0

133.78

137.76

mmol/24h

0.10

Other symptoms and signs involving the nervous and musculoskeletal systems

3.50

2.05

1.0

1.1

130.35

137.23

mmol/24h

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.90

2.00

1.1

111.38

137.33

mmol/24h

—

Anxiety disorders, excluding more controls

2.60

1.98

1.1

149.06

144.33

mmol/24h

0.10

Noninflammatory disorders of female genital tract

3.35

1.96

1.0

1.3

113.07

129.56

mmol/24h

—

Neurological diseases

2.42

1.90

1.1

122.93

148.62

mmol/24h

1.31

Pain in limb

2.49

1.86

1.0

1.1

139.05

146.82

mmol/24h

0.17

Parasetamol

2.37

1.83

1.1

126.54

149.33

mmol/24h

0.69

Complications of labour and delivery

2.79

1.82

1.1

120.22

128.01

mmol/24h

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2.32

1.75

1.1

117.00

150.05

mmol/24h

1.72

Triptan medication for migraine, single purchase ok

2.32

1.75

1.1

117.00

150.05

mmol/24h

1.72

Syncope and collapse

4.03

1.74

1.2

1.0

183.63

140.49

mmol/24h

—

Hernia of abdominal wall

3.33

1.74

1.0

1.1

183.12

139.83

mmol/24h

—

Other heart diseases, wide

2.24

1.73

1.2

1.0

142.28

141.20

mmol/24h

0.02

Procreative management

3.37

1.72

1.2

1.1

110.49

142.93

mmol/24h

—

Endocrine, nutritional and metabolic diseases

2.28

1.71

1.3

1.1

134.43

136.06

mmol/24h

0.04

Used for control exclusion in common control thyroid runs

2.15

1.63

1.3

1.1

135.93

145.11

mmol/24h

0.24

Neoplasms

2.18

1.58

1.4

1.0

133.04

149.33

mmol/24h

0.46

Depression medications

3.35

1.57

1.2

1.0

128.55

124.86

mmol/24h

—

Spondylosis

3.03

1.56

1.0

1.1

144.89

157.61

mmol/24h

—

Dorsopathies

2.10

1.55

1.0

1.2

133.76

148.11

mmol/24h

0.44

Other soft tissue disorders, not elsewhere classified

2.18

1.52

1.0

1.2

138.38

149.01

mmol/24h

0.26

Anxiety (asthma-related co-morbidities)

2.53

1.51

1.1

155.30

136.80

mmol/24h

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.51

1.50

1.1

1.0

157.31

139.60

mmol/24h

—

Selective serotonin reuptake inhibitors

2.18

1.46

1.0

1.1

153.19

139.66

mmol/24h

0.40

Labour and delivery complicated by fetal stress [distress]

3.34

1.44

1.0

136.86

120.66

mmol/24h

—

Other diseases of intestines

2.04

1.41

1.2

1.1

157.44

139.27

mmol/24h

0.57

Triptan medication for migraine, min. 3 purchases

2.29

1.40

1.0

1.1

112.90

143.17

mmol/24h

—

Disorders of choroid and retina

0.00

1.37

0.0

1.1

—

140.42

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2.62

1.36

1.1

118.95

127.01

mmol/24h

—

Cardiac arrhythmias

2.20

1.33

1.1

1.0

136.46

133.24

mmol/24h

—

Symptoms and signs involving the skin and subcutaneous tissue

2.34

1.28

1.0

1.1

137.96

138.76

mmol/24h

—

Meniscus derangement

2.57

1.28

1.0

1.1

170.55

148.25

mmol/24h

—

Endometriosis

2.97

1.28

1.0

1.1

142.60

118.43

mmol/24h

—

Mood disorders, excluding more controls

2.17

1.27

1.2

1.1

136.79

144.33

mmol/24h

—

Opioids

1.95

1.24

1.2

1.0

143.00

141.13

mmol/24h

0.04

Other anxiety disorders

2.22

1.23

1.1

155.46

135.02

mmol/24h

—

Dental caries 2 and operation codes, only avohilmo

2.26

1.23

1.0

1.2

131.35

133.89

mmol/24h

—

Soft tissue disorders

1.93

1.20

1.0

1.2

137.26

148.88

mmol/24h

0.30

Pure hypercholesterolaemia

0.00

1.20

0.0

1.1

—

152.03

—

Disorders of skin appendages

0.00

1.16

0.0

1.1

—

142.70

—

Neurotic, stress-related and somatoform disorders

1.95

1.14

1.1

149.06

136.10

mmol/24h

0.40

Dizziness and giddiness

2.37

1.13

1.0

122.31

142.48

mmol/24h

—

Anxiety disorders

1.95

1.13

1.1

149.06

136.10

mmol/24h

0.40

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2.20

1.08

1.1

1.0

134.87

129.88

mmol/24h

—

Diseases of male genital organs

2.53

1.06

1.0

1.1

157.10

180.88

mmol/24h

—

All anxiety disorders

2.01

1.05

1.1

155.30

135.44

mmol/24h

—

Neurological diseases, wide definition

2.20

1.05

1.1

1.3

112.45

134.90

mmol/24h

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.98

1.04

1.1

1.0

135.78

136.56

mmol/24h

—

Other dorsopathies, not elsewhere classified

1.86

1.03

1.0

1.2

132.50

148.11

mmol/24h

0.50

Other retinal disorders

0.00

0.99

0.0

1.0

—

134.80

—

Other heart diseases

2.01

0.98

1.1

1.0

137.12

138.41

mmol/24h

—

Fracture of lower leg, including ankle

0.00

0.97

0.0

1.1

—

137.91

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.97

0.97

1.1

1.0

134.87

134.13

mmol/24h

—

Gastrointestinal diseases

2.11

0.94

1.1

1.0

121.48

133.53

mmol/24h

—

Disorders of breast

2.22

0.93

1.2

1.0

130.23

128.38

mmol/24h

—

Other neurological diseases

2.19

0.92

1.0

116.68

140.62

mmol/24h

—

Other acute lower respiratory infections

2.12

0.90

1.0

1.1

176.79

143.64

mmol/24h

—

Examination and observation for other reasons

1.95

0.90

1.1

1.0

130.00

158.18

mmol/24h

—

Spondylopathies

1.94

0.90

1.0

1.1

141.58

147.83

mmol/24h

—

Implicit Sepsis

2.03

0.87

1.2

1.0

130.86

139.00

mmol/24h

—

Dental caries 3, only avohilmo

1.78

0.83

1.1

1.0

111.09

163.60

mmol/24h

—

Dental caries 3

1.78

0.82

1.1

1.0

111.09

163.60

mmol/24h

—

Headache

1.86

0.80

1.2

1.0

126.43

137.06

mmol/24h

—

Bacterial pneumonia (organism specified)

0.00

0.79

0.0

1.0

—

137.00

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

0.00

0.79

0.0

1.1

—

132.31

—

Erysipelas

0.00

0.79

0.0

1.0

—

142.35

—

Mouth breathing

0.00

0.79

0.0

1.0

—

140.73

—

Viral infections characterized by skin and mucous membrane lesions

0.00

0.79

0.0

1.0

—

138.56

—

Obesity, other/unspecified

0.00

0.79

0.0

1.0

—

130.04

—

Other arrhythmias

1.84

0.79

1.0

128.72

135.19

mmol/24h

—

Open wound of head

0.00

0.79

0.0

1.1

—

139.48

—

Other viral diseases

0.00

0.78

0.0

1.2

—

136.33

—

False labour

2.24

0.77

1.0

131.70

122.19

mmol/24h

—

Cardiovascular diseases (excluding rheumatic etc)

1.73

0.77

1.1

1.0

111.42

138.85

mmol/24h

—

Dental caries 2, only avohilmo

1.69

0.75

1.0

1.1

127.90

141.25

mmol/24h

—

Dental caries, including avohilmo

1.88

0.75

1.1

106.39

170.36

mmol/24h

—

Dental caries 2

1.68

0.75

1.0

1.1

127.90

141.25

mmol/24h

—

Gingivitis and periodontal diseases

1.66

0.74

1.1

1.0

145.14

139.74

mmol/24h

—

Other diseases of hard tissues of teeth

1.86

0.74

1.1

1.0

143.97

139.74

mmol/24h

—

Chronic diseases of tonsils and adenoids

1.63

0.73

1.2

1.1

132.35

152.84

mmol/24h

—

Dental pulpitis 2, only avohilmo

1.79

0.72

1.1

106.39

169.21

mmol/24h

—

Dental caries 1, only avohilmo

1.79

0.72

1.1

106.39

169.21

mmol/24h

—

Dental caries 1

1.79

0.72

1.1

106.39

169.21

mmol/24h

—

Constipation

1.73

0.70

1.0

1.1

155.69

135.26

mmol/24h

—

Depression

1.68

0.69

1.2

1.1

136.79

145.50

mmol/24h

—

Diverticular disease of intestine

1.84

0.67

1.0

1.1

143.51

151.07

mmol/24h

—

Pregnancy with abortive outcome

1.74

0.65

1.0

139.16

126.91

mmol/24h

—

Symptoms and signs involving the circulatory and respiratory systems

1.62

0.64

1.1

137.89

149.59

mmol/24h

0.33

Codeine or tramadol medication

1.60

0.63

1.0

1.1

155.22

139.32

mmol/24h

0.42

Pain (limb, back, neck, head abdominally)

1.60

0.62

1.1

1.0

125.09

147.55

mmol/24h

—

Temporomandibular joint disorders, including avohilmo

1.66

0.61

1.0

1.1

130.48

136.79

mmol/24h

—

Glaucoma

0.00

0.61

0.0

1.1

—

130.15

—

Artrosis, including avohilmo

1.57

0.60

1.1

1.0

125.90

145.19

mmol/24h

—

Allergic asthma (mode), excluding more controls

0.00

0.60

0.0

1.0

—

140.29

—

Bacterial pneumoniae

0.00

0.60

0.0

1.1

—

130.70

—

Obesity related asthma

0.00

0.60

0.0

1.1

—

137.15

—

Other medical care

0.00

0.60

0.0

1.1

—

130.47

—

Mood [affective] disorders

1.60

0.60

1.2

1.1

136.79

145.50

mmol/24h

—

Mood disorders

1.60

0.60

1.2

1.1

136.79

145.50

mmol/24h

—

Codeine

1.62

0.59

1.0

151.42

142.65

mmol/24h

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.00

0.59

0.0

1.0

—

138.95

—

Pain in throat and chest

1.53

0.59

1.1

131.11

146.42

mmol/24h

—

Special screening examination for infectious and parasitic diseases

0.00

0.59

0.0

1.0

—

148.78

—

Migraine

1.76

0.58

1.0

1.1

115.88

137.52

mmol/24h

—

Sulfasalazine

0.00

0.58

0.0

1.0

—

137.33

—

Episodal and paroxysmal disorders

1.57

0.58

1.1

132.75

141.16

mmol/24h

0.24

Dental pulpitis 2

1.71

0.58

1.2

1.1

105.48

167.90

mmol/24h

—

Dental caries 2 and operation codes

1.48

0.57

1.0

1.1

131.35

140.30

mmol/24h

—

Any reimbursement code in KELA

1.56

0.56

1.1

132.74

144.07

mmol/24h

—

Acute appendicitis, no complications

1.62

0.55

1.0

1.1

141.53

139.70

mmol/24h

—

Asthma/COPD (KELA code 203)

1.51

0.55

1.2

1.1

118.19

149.73

mmol/24h

—

Symptoms and signs involving the urinary system

1.60

0.55

1.5

1.0

147.88

148.63

mmol/24h

—

Acute sinusitis

1.60

0.55

1.2

1.0

112.42

138.27

mmol/24h

—

Dorsalgia

1.43

0.52

1.0

1.2

130.46

148.11

mmol/24h

—

Artificial joint operation, meniscal resection

1.54

0.52

1.0

1.1

162.67

147.54

mmol/24h

—

Autoimmune diseases

1.52

0.52

1.4

1.1

137.71

145.31

mmol/24h

0.18

Diseases of the respiratory system

1.52

0.49

1.1

1.0

132.01

143.69

mmol/24h

—

Dental pulpitis 4, only avohilmo

0.59

0.48

1.2

1.1

124.51

146.53

mmol/24h

—

Dental pulpitis 1, only avohilmo

0.59

0.48

1.2

1.1

124.51

146.53

mmol/24h

—

Tramadol

1.45

0.46

1.1

1.0

124.78

142.59

mmol/24h

—

Other obstetric conditions, not elsewhere classified

1.62

0.43

1.0

1.1

130.71

121.82

mmol/24h

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.62

0.43

1.0

1.1

130.71

121.82

mmol/24h

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.59

0.43

1.0

1.1

145.79

134.67

mmol/24h

—

COPD/asthma related infections

1.47

0.42

1.1

134.80

142.95

mmol/24h

—

COPD/asthma/ILD related infections

1.47

0.42

1.1

134.80

142.95

mmol/24h

—

1.47

0.42

1.1

126.33

143.40

mmol/24h

—

Spontaneous abortion

1.55

0.42

1.0

137.90

128.58

mmol/24h

—

Benzodiazepine use

1.39

0.42

1.0

1.1

146.59

141.84

mmol/24h

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.42

0.0

1.0

—

138.53

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

134.13

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.00

0.41

0.0

1.1

—

120.55

—

Nonsuppurative otitis media

0.00

0.41

0.0

1.2

—

138.99

—

Renal failure

0.00

0.41

0.0

1.1

—

132.67

—

Myocardial infarction, strict

0.00

0.41

0.0

1.1

—

136.30

—

Other septicaemia

0.00

0.41

0.0

1.1

—

132.41

—

Strabismus

0.00

0.41

0.0

1.1

—

124.82

—

Endometriosis ASRM stages 1,2

0.00

0.41

0.0

1.1

—

117.61

—

Fracture of skull and facial bones

0.00

0.41

0.0

1.1

—

128.80

—

Alcohol dependence

0.00

0.41

0.0

1.1

—

140.24

—

Retinal detachments and breaks

0.00

0.41

0.0

1.1

—

130.12

—

Basal cell carcinoma

0.00

0.41

0.0

1.1

—

126.20

—

Migraine without aura

0.00

0.41

0.0

1.0

—

132.79

—

Poisoning by medicine

0.00

0.41

0.0

1.1

—

129.01

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.41

0.0

1.1

—

134.42

—

Suicide or other Intentional self-harm

0.00

0.41

0.0

1.1

—

129.01

—

Malignant neoplasm of breast, HER-positive

0.00

0.41

0.0

1.1

—

130.58

—

Medicines for HER+ breast cancer

0.00

0.41

0.0

1.1

—

130.58

—

Abnormal findings on diagnostic imaging of lung

0.00

0.41

0.0

1.1

—

132.73

—

Basal cell carcinoma, including avohilmo

0.00

0.41

0.0

1.1

—

126.20

—

Septicaemia

0.00

0.41

0.0

1.1

—

136.12

—

Other cataract

0.00

0.41

0.0

1.1

—

135.80

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.0

—

141.11

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.0

—

141.11

—

Poisoning by drugs, medicaments and biological substances

0.00

0.40

0.0

1.1

—

130.74

—

Effects of foreign body entering through natural orifice

0.00

0.40

0.0

1.1

—

137.00

—

Rheumatoid arthritis, including avohilmo

0.00

0.40

0.0

1.1

—

131.95

—

Myocardial infarction

0.00

0.40

0.0

1.1

—

133.48

—

Injuries to the hip and thigh

0.00

0.39

0.0

1.1

—

134.70

—

Allergic asthma (mode)

0.00

0.39

0.0

1.0

—

137.75

—

Bacterial pneumonia, not elsewhere classified

0.00

0.39

0.0

1.1

—

127.41

—

Deviated nasal septum

0.00

0.39

0.0

1.0

—

148.26

—

Epilepsy

0.00

0.39

0.0

1.0

—

144.40

—

Other diseases of upper respiratory tract

1.34

0.38

1.1

122.87

152.84

mmol/24h

—

Diseases of the eye and adnexa

1.43

0.38

1.0

1.2

136.49

143.87

mmol/24h

—

Acute appendicitis

1.35

0.34

1.0

1.1

141.53

143.13

mmol/24h

—

Asthma, including avohilmo

1.38

0.33

1.2

1.1

125.79

147.77

mmol/24h

—

Appendicitis, broad definition

1.31

0.33

1.0

1.1

141.53

143.13

mmol/24h

—

Diseases of appendix

1.30

0.33

1.0

1.1

141.53

143.13

mmol/24h

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.42

0.33

1.0

121.87

158.18

mmol/24h

—

Cardiovascular diseases

1.31

0.31

1.0

133.60

135.67

mmol/24h

—

Hernia

1.32

0.31

1.0

1.1

145.41

134.77

mmol/24h

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.32

0.31

1.3

1.0

122.78

146.88

mmol/24h

—

Injury, poisoning and certain other consequences of external causes

1.30

0.31

1.1

1.0

109.14

144.98

mmol/24h

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.30

0.31

1.1

1.0

132.01

142.12

mmol/24h

—

Dental caries 3 and operation codes

1.28

0.30

1.1

1.0

108.59

156.03

mmol/24h

—

Injuries to the wrist and hand

1.32

0.28

1.0

1.1

125.98

146.74

mmol/24h

—

Other diseases of urinary system

1.29

0.28

1.1

129.64

142.27

mmol/24h

—

Acute upper respiratory infections

1.25

0.28

1.1

1.0

128.36

144.71

mmol/24h

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.22

0.25

1.0

1.1

145.29

144.47

mmol/24h

—

Certain infectious and parasitic diseases

0.73

0.25

1.2

1.1

148.09

142.76

mmol/24h

—

Dental pulpitis 4

0.72

0.25

1.2

1.1

139.53

144.95

mmol/24h

—

Diseases of pulp and periapical tissues, including avohilmo

0.72

0.25

1.2

1.1

139.53

144.95

mmol/24h

—

Dental pulpitis 1

0.72

0.25

1.2

1.1

139.53

144.95

mmol/24h

—

ILD medications

0.73

0.25

1.2

1.0

121.42

144.29

mmol/24h

—

Gonarthrosis,primary

1.37

0.24

1.0

1.1

168.58

145.30

mmol/24h

—

Chronic lower respiratory diseases

1.29

0.22

1.2

1.1

117.57

149.73

mmol/24h

—

Hypertensive diseases (excluding secondary)

1.21

0.22

1.0

127.72

134.28

mmol/24h

—

Dental pulpitis 3

0.00

0.22

0.0

1.4

—

145.67

—

Other disorders of urethra and urinary system

1.21

0.22

1.0

99.03

134.28

mmol/24h

—

Coronary angioplasty

0.00

0.22

0.0

1.0

—

147.41

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.21

0.0

1.0

—

141.25

—

Rheumatoid arthritis

0.00

0.21

0.0

1.2

—

124.68

—

Vocal cord dysfunction

0.00

0.21

0.0

1.0

—

141.21

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.21

0.0

1.1

—

124.48

—

Acute nasopharyngitis (common cold)

0.00

0.21

0.0

1.0

—

138.92

—

Seropositive rheumatoid arthritis

0.00

0.21

0.0

1.1

—

125.88

—

Eating disorders

0.00

0.21

0.0

1.1

—

119.00

—

Cardiodefibrillation

0.00

0.21

0.0

1.0

—

145.63

—

Eustachian salpingitis and obstruction

0.00

0.21

0.0

1.1

—

131.70

—

Excessive vomiting in pregnancy

0.00

0.21

0.0

1.1

—

119.62

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

1.1

—

128.19

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

1.1

—

128.19

—

Bitten or struck by other mammals

0.00

0.21

0.0

1.1

—

125.27

—

Early lumbar disc prolapse operation

0.00

0.21

0.0

1.1

—

126.93

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.21

0.0

1.1

—

128.19

—

Type 1 diabetes, definitions combined

0.00

0.21

0.0

1.1

—

128.19

—

Thyroiditis, ILD-related definition

0.00

0.21

0.0

1.1

—

117.96

—

Polycystic ovarian syndrome, broad definition

0.00

0.21

0.0

1.1

—

124.74

—

Ethmoidectomy

0.00

0.21

0.0

1.1

—

126.78

—

Sarcoidosis

0.00

0.21

0.0

1.1

—

126.78

—

Focal epilepsy, strict definition

0.00

0.21

0.0

1.1

—

124.47

—

Noninfectious colitis NAS

0.00

0.21

0.0

1.1

—

125.27

—

Assault

0.00

0.21

0.0

1.1

—

130.59

—

Burns and corrosions

0.00

0.21

0.0

1.1

—

124.47

—

Superficial injury of head

0.00

0.21

0.0

1.1

—

121.26

—

Superficial injury of thorax

0.00

0.21

0.0

1.1

—

124.47

—

Spondylopathies (FG)

0.00

0.21

0.0

1.1

—

117.95

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.21

0.0

1.1

—

126.25

—

L02BA Anti-estrogens

0.00

0.21

0.0

1.1

—

122.25

—

Methotrexate

0.00

0.21

0.0

1.1

—

128.37

—

Chondropathies

0.00

0.21

0.0

1.1

—

126.25

—

Insulin, fast-acting (human)

0.00

0.21

0.0

1.1

—

133.21

—

Other female pelvic inflammatory diseases

0.00

0.21

0.0

1.1

—

120.17

—

Migraine without aura and triptan purchases

0.00

0.21

0.0

1.1

—

127.26

—

Glomerular diseases

0.00

0.21

0.0

1.1

—

124.48

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.21

0.0

1.1

—

126.78

—

Psoriasis vulgaris

0.00

0.21

0.0

1.1

—

123.33

—

Certain disorders involving the immune mechanism

0.00

0.21

0.0

1.1

—

128.35

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

1.1

—

125.16

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

139.41

—

Other disorders of patella

0.00

0.21

0.0

1.1

—

121.07

—

Nasal polyp

0.00

0.21

0.0

1.0

—

127.14

—

Use of pramipexole

0.00

0.21

0.0

1.1

—

133.40

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.21

0.0

1.0

—

135.59

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.21

0.0

1.0

—

134.81

—

Other gastritis (incl. Duodenitis)

0.00

0.21

0.0

1.1

—

126.78

—

Fibroblastic disorders

0.00

0.21

0.0

1.1

—

149.98

—

Dysphagia

0.00

0.21

0.0

1.1

—

139.61

—

Diagnoses used for exclusion with ILD

0.00

0.21

0.0

1.1

—

128.35

—

L02BG Aromatase inhibitors

0.00

0.21

0.0

1.1

—

125.34

—

Intestinal stricture

0.00

0.21

0.0

1.1

—

133.40

—

Asthma and allergy, excluding more controls

0.00

0.21

0.0

1.0

—

132.78

—

Asthma and allergy

0.00

0.21

0.0

1.0

—

132.78

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

135.85

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.21

0.0

1.0

—

122.70

—

Non-invasive ventilation

0.00

0.21

0.0

1.0

—

138.85

—

Myocardial infarction, without ST-elevation

0.00

0.21

0.0

1.0

—

142.57

—

Prolonged pregnancy

0.00

0.21

0.0

1.0

—

126.20

—

Perineal laceration during delivery

0.00

0.21

0.0

1.0

—

121.29

—

0.00

0.21

0.0

1.1

—

117.81

—

Allergic contact dermatitis

0.00

0.21

0.0

1.1

—

119.37

—

Inflammatory disease of uterus

0.00

0.21

0.0

1.1

—

118.90

—

Corneal ulcer

0.00

0.21

0.0

1.1

—

124.51

—

Appendectomy

1.17

0.21

1.0

1.1

153.41

134.62

mmol/24h

—

Atrial fibrillation and flutter with reimbursement

0.00

0.21

0.0

1.0

—

147.73

—

Retention of urine

0.00

0.21

0.0

1.1

—

132.46

—

Hallux valgus (acquired)

0.00

0.21

0.0

1.2

—

124.68

—

Organic, including symptomatic, mental disorders

0.00

0.21

0.0

1.1

—

134.51

—

Emergency coronary revascularization (for ACS)

0.00

0.21

0.0

1.0

—

145.63

—

Diseases of the musculoskeletal system and connective tissue

1.25

0.21

1.0

1.3

122.71

142.42

mmol/24h

—

Peripheral artery disease

0.00

0.21

0.0

1.0

—

142.56

—

Salpingitis and oophoritis

0.00

0.21

0.0

1.1

—

129.60

—

Bipolar affective disorders

0.00

0.21

0.0

1.0

—

128.61

—

L04AA Selective immunosuppressants

0.00

0.21

0.0

1.1

—

123.54

—

Otitis externa

0.00

0.21

0.0

1.1

—

123.54

—

Nontoxic goitre/thyroid nodule

0.00

0.21

0.0

1.1

—

127.24

—

Other enthesopathies

0.00

0.21

0.0

1.1

—

144.28

—

Glaucoma suspect

0.00

0.21

0.0

1.1

—

126.35

—

Spondyloarthritis

0.00

0.21

0.0

1.1

—

123.54

—

Focal epilepsy

0.00

0.21

0.0

1.1

—

123.54

—

Other viral diseases, not elsewhere classified

0.00

0.21

0.0

1.1

—

123.54

—

Coronary revascularization (ANGIO or CABG)

0.00

0.20

0.0

1.0

—

145.97

—

Nausea and vomiting

0.00

0.20

0.0

1.1

—

134.86

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.0

—

138.87

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.0

—

135.85

—

Oxycodone

0.00

0.20

0.0

1.0

—

132.01

—

Medical observation and evaluation for suspected diseases and conditions

1.23

0.20

1.3

1.0

108.12

158.18

mmol/24h

—

Coxarthrosis, primary, with hip surgery

0.00

0.20

0.0

1.1

—

134.08

—

Fitting and adjustment of other devices

0.00

0.20

0.0

1.1

—

128.63

—

Dyspnoea

1.24

0.20

1.0

1.1

137.47

144.26

mmol/24h

—

Emotionally unstable personality disorder

0.00

0.20

0.0

1.1

—

124.02

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.20

0.0

1.1

—

125.25

—

Adverse effects, not elsewhere classified

0.00

0.20

0.0

1.1

—

125.25

—

Substance use, excluding alcohol

0.00

0.20

0.0

1.1

—

129.69

—

Other disorders of bone

0.00

0.20

0.0

1.1

—

121.88

—

Fall on and from stairs and steps

0.00

0.20

0.0

1.1

—

128.97

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.20

0.0

1.1

—

128.80

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.20

0.0

1.1

—

128.80

—

Seropositive rheumatoid arthritis, wide

0.00

0.20

0.0

1.1

—

128.80

—

Other noninfective gastroenteritis and colitis

0.00

0.20

0.0

1.1

—

128.97

—

Other strabismus

0.00

0.20

0.0

1.1

—

123.20

—

Persons encountering health services for examination and investigation

1.20

0.20

1.2

1.0

106.61

158.18

mmol/24h

—

Dentinal caries

0.00

0.20

0.0

1.0

—

132.41

—

Exclusions for E4_PCOS_CONSORTIUM

1.21

0.20

1.0

131.22

137.89

mmol/24h

—

Malignant neoplasm of digestive organs

0.00

0.20

0.0

1.1

—

133.24

—

Dental caries 1 and operation codes

1.18

0.20

1.2

1.0

109.13

157.34

mmol/24h

—

Cystitis

1.18

0.19

1.2

1.1

156.31

138.88

mmol/24h

—

Sleep apnoea

1.16

0.19

1.3

1.0

138.97

138.05

mmol/24h

—

Abnormalities of breathing

1.22

0.18

1.0

1.1

138.41

149.59

mmol/24h

—

Sleep apnoea, including avohilmo

1.23

0.18

1.3

1.0

146.72

132.82

mmol/24h

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.19

0.18

1.0

1.1

156.52

141.28

mmol/24h

—

Sleep disorders (combined)

1.18

0.18

1.3

1.0

148.82

135.73

mmol/24h

—

Other external causes of accidental injury

0.74

0.17

1.0

1.1

117.18

146.99

mmol/24h

—

Nerve, nerve root and plexus disorders

1.13

0.17

1.0

1.1

129.43

146.10

mmol/24h

—

Oral corticosteroids

0.72

0.17

1.2

1.0

122.30

144.79

mmol/24h

—

Arthropathies

1.20

0.17

1.0

1.2

133.99

144.55

mmol/24h

—

Symptoms and signs involving the digestive system and abdomen

1.15

0.17

1.0

1.1

135.80

148.95

mmol/24h

—

First line medication for Crohn's disease

0.76

0.16

1.3

1.0

119.82

144.80

mmol/24h

—

ILD medications: prednisolone, methylprednisolone, prednisone

0.77

0.16

1.2

1.0

121.42

145.54

mmol/24h

—

Falls/tendency to fall

0.80

0.15

1.4

1.1

145.06

144.61

mmol/24h

—

Diseases of the ear and mastoid process

0.80

0.15

1.0

1.1

139.31

138.83

mmol/24h

—

Dental operations, only avohilmo

1.16

0.10

1.2

1.0

123.19

157.65

mmol/24h

—

Shoulder lesions

1.18

0.10

1.0

1.1

118.00

152.30

mmol/24h

—

Congenital malformations, deformations and chromosomal abnormalities

1.14

0.10

1.0

1.1

105.99

144.70

mmol/24h

—

Exposure to other specified factors

1.12

0.10

1.0

1.1

154.76

145.06

mmol/24h

—

Diseases of oral cavity, salivary glands and jaws

1.10

0.09

1.2

1.0

139.84

139.74

mmol/24h

—

Other pulmonary diagnosis

1.13

0.08

1.1

1.0

114.40

152.56

mmol/24h

—

Excluding asthma or asthma-COPD overlap

1.13

0.08

1.1

1.0

114.40

152.56

mmol/24h

—

COPD differential diagnosis

1.13

0.08

1.1

1.0

114.40

152.56

mmol/24h

—

ILD differential diagnosis

1.13

0.08

1.1

1.0

114.40

152.56

mmol/24h

—

Any event in cancer register

0.78

0.08

1.2

1.0

117.67

148.44

mmol/24h

—

Pneumonias (Asthma/COPD co-morbidities)

0.79

0.08

1.2

1.1

147.92

144.17

mmol/24h

—

All pneumoniae

0.78

0.08

1.2

1.1

147.92

144.17

mmol/24h

—

Other joint disorders

1.10

0.08

1.0

1.2

148.56

144.55

mmol/24h

—

Benign neoplasms

1.07

0.08

1.4

1.0

134.87

150.40

mmol/24h

—

Use of hypnotics and sedatives

0.85

0.08

1.2

1.0

147.21

142.59

mmol/24h

—

Diseases of the skin and subcutaneous tissue

0.79

0.08

1.0

1.2

156.90

147.90

mmol/24h

—

Influenza and pneumonia

1.02

0.08

1.1

151.77

142.27

mmol/24h

—

Inflammatory bowel disease treatment related agents

0.79

0.08

1.2

1.0

121.42

144.78

mmol/24h

—

malignant neoplasm of female genital organs

0.00

0.0

1.1

—

119.04

—

Sequelae of injuries of lower limb

0.00

0.0

1.1

—

128.44

—

Other hearing loss

0.00

0.0

1.0

—

132.36

—

Ulcerative proctitis

0.00

0.0

1.2

—

118.81

—

Nontraumatic intracranial haemmorrhage

0.00

0.0

1.0

—

138.68

—

Dermatographic urticaria

0.00

0.0

1.1

—

111.38

—

Primary open-angle glaucoma

0.00

0.0

1.0

—

137.10

—

Benign neoplasms

1.00

0.00

1.4

1.1

134.87

147.08

mmol/24h

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

0.92

0.00

1.2

1.1

147.92

142.95

mmol/24h

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.0

1.1

—

127.37

—

0.92

0.00

1.2

1.1

147.92

142.95

mmol/24h

—

Female infertility, associated with anovulation

0.00

0.0

1.2

—

136.26

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

135.33

—

Thyrotoxicosis with diffuse goitre

0.00

0.0

1.0

—

123.08

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.0

—

129.93

—

Deposits [accretions] on teeth

0.00

0.0

1.0

—

114.05

—

Benign neoplasm: Stomach

0.00

0.0

1.0

—

129.93

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.0

1.0

—

118.89

—

Convalescence

0.00

0.0

1.2

—

118.81

—

Other local infections of skin and subcutaneous tissue

0.00

0.0

1.0

—

138.13

—

Bronchitis

0.91

0.00

1.0

1.1

128.14

141.87

mmol/24h

—

Social phobias

0.00

0.0

1.1

—

123.98

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.1

—

132.39

—

Pilonidal cyst

0.00

0.0

1.1

—

123.18

—

Adalimumab

0.00

0.0

1.1

—

115.46

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.0

1.0

—

138.13

—

External causes of morbidity and mortality

1.00

0.00

1.2

1.0

106.10

142.61

mmol/24h

—

Sulfonylureas

0.00

0.0

1.0

—

140.14

—

L04AD Calcineurin inhibitors

0.00

0.0

1.1

—

129.49

—

Gout

0.00

0.0

1.0

—

126.89

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.0

—

162.55

—

Disorders of psychological development

0.00

0.0

1.0

—

125.37

—

Neuromuscular dysfunction of bladder

0.00

0.0

1.0

—

139.11

—

Distal bite

0.00

0.0

1.6

—

145.03

—

Purpura and other haemorrhagic conditions

0.00

0.0

1.1

—

115.46

—

Recurrent dislocation of patella

0.00

0.0

1.1

—

115.95

—

Persons encountering health services for specific procedures, not carried out

0.00

0.0

1.0

—

118.89

—

Crohn's disease of small intestine

0.00

0.0

1.0

—

118.89

—

Postpartum care and examination

0.00

0.0

1.0

—

117.38

—

Aneurysms, operations, SAH

0.00

0.0

1.0

—

131.05

—

Recurrent dislocation and subluxation of joint

0.00

0.0

1.2

—

111.28

—

Other disorders of amniotic fluid and membranes

0.00

0.0

1.0

—

129.82

—

Melanocytic naevi of other and unspecified parts of face

0.00

0.0

1.0

—

124.41

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.0

—

124.41

—

Benign neoplasm of mouth and pharynx

0.00

0.0

1.0

—

139.11

—

Chronic periodontitis

0.00

0.0

1.0

—

117.42

—

Disorders of parathyroid gland

0.00

0.0

1.0

—

137.30

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

130.96

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.0

1.0

—

128.23

—

Mixed and other personality disorders

0.00

0.0

1.1

—

125.12

—

Benign neoplasm: Colon, unspecified

0.00

0.0

1.0

—

124.30

—

Viral pneumonia

0.00

0.0

1.0

—

121.42

—

Other embolism and thrombosis

0.00

0.0

1.2

—

123.01

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

1.0

—

133.07

—

Haemangioma, any site

0.00

0.0

1.0

—

124.41

—

Other specified/unspecified systemic involvement of connective tissue

0.00

0.0

1.2

—

108.81

—

Congenital malformations of heart and great arteries

0.00

0.0

1.1

—

123.98

—

Diabetic retinopathy

0.00

0.0

1.0

—

194.15

—

Special screening examination for other diseases and disorders

0.00

0.0

1.0

—

149.82

—

0.00

0.0

1.1

—

109.77

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.0

1.2

—

118.81

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

1.0

—

119.32

—

Convergent concomitant strabismus

0.00

0.0

1.1

—

111.38

—

Desensitization to allergens

0.00

0.0

1.2

—

114.17

—

Episcleritis

0.00

0.0

1.2

—

123.01

—

Overexertion and strenuous or repetitive movements

0.00

0.0

1.1

—

123.18

—

Assault by bodily force

0.00

0.0

1.0

—

131.24

—

Unspecified abortion

0.00

0.0

1.2

—

110.17

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.0

1.0

—

131.94

—

Endometriosis of pelvic peritoneum

0.00

0.0

1.1

—

114.04

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.0

1.2

—

133.88

—

Benign neoplasm of major salivary glands

0.00

0.0

1.0

—

129.93

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.0

1.0

—

140.76

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

0.0

1.2

—

118.81

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.0

1.0

—

118.89

—

Benign neoplasm: Colon, unspecified

0.00

0.0

1.0

—

132.67

—

Superficial injury of forearm

0.00

0.0

1.0

—

123.08

—

Superficial injury of shoulder and upper arm

0.00

0.0

1.0

—

123.08

—

Transplanted organ and tissue status

0.00

0.0

1.0

—

130.79

—

Maltreatment syndromes

0.00

0.0

1.0

—

118.89

—

Bell's palsy

0.00

0.0

1.2

—

121.69

—

Hallux rigidus

0.00

0.0

1.2

—

106.79

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.0

1.0

—

119.32

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.0

1.0

—

123.08

—

Allergic urticaria

0.00

0.0

1.1

—

111.38

—

Heart failure and bmi 25plus

0.00

0.0

1.0

—

163.51

—

Open wound of forearm

0.00

0.0

1.0

—

133.49

—

Open wound of lower leg

0.00

0.0

1.1

—

126.49

—

Foreign body on external eye

0.00

0.0

1.0

—

147.42

—

Plantar fascial fibromatosis

0.00

0.0

1.2

—

125.66

—

Hyperparathyroidism

0.00

0.0

1.0

—

127.85

—

Injury of muscle and tendon at lower leg level

0.00

0.0

1.1

—

123.58

—

Acute and transient psychotic disorders

0.00

0.0

1.1

—

119.27

—

Complications of the puerperium, not elsewhere classified

0.00

0.0

1.1

—

112.12

—

Ankylosing spondylitis, strict definition

0.00

0.0

1.0

—

138.13

—

Rash and other nonspecific skin eruption

0.00

0.0

1.1

—

119.09

—

Heartburn

0.00

0.0

1.1

—

121.25

—

Pain associated with micturition

0.00

0.0

1.1

—

118.12

—

Abdominal and pelvic pain

1.01

0.00

1.0

1.1

141.37

148.95

mmol/24h

—

Other contact dermatitis

0.00

0.0

1.1

—

127.48

—

Chronic kidney disease

0.00

0.0

1.0

—

135.36

—

severe traumatic brain injury, does not include concussion

0.00

0.0

1.1

—

135.31

—

Statin medication

0.88

0.00

1.0

1.1

167.77

131.49

mmol/24h

—

Benign neoplasm: Rectum

0.00

0.0

1.0

—

130.96

—

Presbyopia

0.00

0.0

1.1

—

117.98

—

Pacemaker

0.00

0.0

1.0

—

151.19

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

142.95

—

Heterophoria

0.00

0.0

1.0

—

118.89

—

Certain conditions originating in the perinatal period

0.00

0.0

1.5

—

135.74

—

Colectomy operation

0.00

0.0

1.0

—

139.11

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

0.0

1.0

—

137.79

—

Burns and corrosions of external body surface, specified by site

0.00

0.0

1.1

—

123.98

—

Thyroiditis

0.00

0.0

1.1

—

119.27

—

Otitis externa, unspecified

0.00

0.0

1.1

—

115.46

—

Nephropathy related operations

0.00

0.0

1.0

—

123.71

—

Metatarsalgia

0.00

0.0

1.2

—

125.66

—

Divergent concomitant strabismus

0.00

0.0

1.1

—

119.27

—

Benign leiomyoma with endometriosis

0.00

0.0

1.0

—

118.59

—

Other ulcerative colitis

0.00

0.0

1.2

—

118.81

—

Other bursopathies

0.00

0.0

1.1

—

130.51

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.0

1.1

—

119.27

—

Infective dermatitis

0.00

0.0

1.1

—

128.44

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

1.2

—

125.66

—

Acute renal failure

0.00

0.0

1.0

—

143.13

—

Rosacea

0.00

0.0

1.1

—

118.34

—

Benign mammary dysplasia

0.00

0.0

1.0

—

110.72

—

Impetigo

0.00

0.0

1.0

—

118.89

—

Hypertrophic disorders of skin

0.00

0.0

1.2

—

118.81

—

Lung cancer and mesothelioma

0.00

0.0

1.0

—

135.86

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.1

—

121.20

—

Acne vulgaris

0.00

0.0

1.2

—

114.17

—

Parodontitis, under 40 years and operation codes

0.00

0.0

1.0

—

136.92

—

Parodontitis, operation under 40 years and operation codes

0.00

0.0

1.0

—

136.92

—

Dental pulpitis 3, only avohilmo

0.00

0.0

1.4

—

138.76

—

Other or unspecified ileus, impaction or obstruction

0.00

0.0

1.0

—

136.97

—

Other disorders of the genitourinary system

0.00

0.0

1.1

—

120.06

—

Other diseases of the respiratory system

0.00

0.0

1.0

—

134.75

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

1.1

—

112.12

—

Retinal breaks without detachment

0.00

0.0

1.0

—

128.23

—

Anorexia (incl.atypical)

0.00

0.0

1.1

—

118.62

—

Eating disorder

0.00

0.0

1.1

—

119.02

—

Fracture of lumbar spine and pelvis

0.00

0.0

1.0

—

139.90

—

Acne

0.00

0.0

1.4

—

135.23

—

Speech and linguistic disorders

0.00

0.0

1.0

—

125.37

—

Parodontitis, under 40 years, or operation codes

0.00

0.0

1.0

—

136.93

—

Other follicular disorders

0.00

0.0

1.2

—

115.14

—

Diseases of peritoneum

0.00

0.0

1.0

—

124.41

—

Scoliosis

0.00

0.0

1.2

—

126.38

—

Acute appendicitis, with complications

0.00

0.0

1.1

—

129.37

—

Fentanyl

0.00

0.0

1.0

—

138.13

—

Otalgia

0.00

0.0

1.2

—

114.17

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.0

1.0

—

138.13

—

Type1 diabetes, definitions combined, early onset

0.00

0.0

1.0

—

125.29

—

Candidiasis

0.00

0.0

1.1

—

118.63

—

Deep endometriosis

0.00

0.0

1.2

—

108.24

—

Other congenital malformations

0.00

0.0

1.1

—

111.38

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

129.93

—

Early lumbar disc prolapse, operated

0.00

0.0

1.1

—

130.53

—

Conductive hearing loss, unspecified

0.00

0.0

1.0

—

125.29

—

Degeneration of macula and posterior pole

0.00

0.0

1.0

—

133.95

—

Any gastric operation

0.97

0.00

1.0

1.2

125.94

138.33

mmol/24h

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.0

1.1

—

140.33

—

Polycystic ovarian syndrome

0.00

0.0

1.2

—

115.26

—

GASTRO-related operations

0.97

0.00

1.0

1.2

125.94

138.33

mmol/24h

—

Demyelinating diseases of the central nervous system

0.00

0.0

1.1

—

129.32

—

FESS (DNB20)

0.00

0.0

1.1

—

128.44

—

Diseases of oesophagus, stomach and duodenum

0.91

0.00

1.2

1.1

170.25

138.75

mmol/24h

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.0

1.1

—

117.75

—

Obsessive-compulsive disorder

0.00

0.0

1.2

—

113.81

—

Metabolic disorders

1.01

0.00

1.0

1.1

145.88

142.60

mmol/24h

—

Rheumatism, unspecified

0.00

0.0

1.1

—

142.83

—

Gout, FINNGEN

0.00

0.0

1.0

—

132.08

—

Stenosis and insufficiency of lacrimal passages

0.00

0.0

1.1

—

118.12

—

Nontoxic multinodular goitre

0.00

0.0

1.0

—

119.01

—

Suggestive for eosinophilic asthma

0.00

0.0

1.2

—

118.81

—

Secondary hypertension

0.00

0.0

1.0

—

129.69

—

Lesion of ulnar nerve

0.00

0.0

1.1

—

126.93

—

Other sleep disorders

0.00

0.0

1.0

—

135.65

—

Diabetic retinopathy, excluding more controls

0.00

0.0

1.0

—

194.15

—

Infectious mononucleosis

0.00

0.0

1.0

—

125.18

—

Dialysis, with operation codes

0.00

0.0

1.0

—

123.71

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.0

1.0

—

134.75

—

Other appendicitis

0.00

0.0

1.2

—

123.01

—

Other hammer toe(s) (acquired)

0.00

0.0

1.0

—

124.39

—

Nonspecific lymphadenitis

0.00

0.0

1.1

—

118.12

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.0

—

129.93

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.0

—

135.14

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.0

1.0

—

130.66

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

134.75

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.1

—

119.27

—

Ovarian dysfunction

0.00

0.0

1.1

—

112.40

—

Graves disease, strict definition

0.00

0.0

1.1

—

121.19

—

Benign neoplasm of mouth and pharynx

0.00

0.0

1.0

—

144.53

—

Nonalcoholic fatty liver disease

0.00

0.0

1.0

—

129.93

—

Collagenous colitis

0.00

0.0

1.2

—

118.81

—

Haemangioma, any site

0.00

0.0

1.2

—

123.01

—

Varicella [chickenpox]

0.00

0.0

1.0

—

133.92

—

Diseases of the myoneural junction and muscle

0.00

0.0

1.0

—

142.95

—

Disorders of muscles

0.00

0.0

1.2

—

131.70

—

Nail disorders

0.00

0.0

1.0

—

118.89

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

0.0

1.2

—

117.01

—

Non-ischemic cardiomyopathy

0.00

0.0

1.0

—

159.12

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

138.88

—

Colorectal cancer

0.00

0.0

1.0

—

140.76

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

138.68

—

Paralytic ileus and intestinal obstruction

0.00

0.0

1.1

—

127.76

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

110.72

—

Optic neuritis

0.00

0.0

1.2

—

118.81

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.0

1.1

—

111.35

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.0

1.1

—

112.12

—

Sicca syndrome [Sjögren]

0.00

0.0

1.2

—

106.81

—

Disorders of optic nerve and visual pathways

0.00

0.0

1.1

—

119.27

—

Persons encountering health services in other circumstances, wide

0.99

0.00

1.0

1.1

145.91

144.47

mmol/24h

—

Undetermined asthma

0.00

0.0

1.0

—

137.30

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.0

1.1

—

115.44

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

134.75

—

Flat foot [pes planus] (acquired)

0.00

0.0

1.1

—

115.44

—

Abnormal findings on diagnostic imaging of other body structures

0.00

0.0

1.1

—

119.27

—

Intestinal infectious diseases

0.86

0.00

1.2

1.1

154.49

143.15

mmol/24h

—

Lower back pain or/and sciatica

0.95

0.00

1.0

1.1

131.58

142.91

mmol/24h

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

1.2

—

123.01

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.84

0.00

1.2

1.1

147.92

145.15

mmol/24h

—

Other peripheral vascular diseases

0.00

0.0

1.2

—

115.14

—

Hypopituitarism

0.00

0.0

1.0

—

133.49

—

Diplopia

0.00

0.0

1.0

—

115.21

—

Osteoporosis

0.00

0.0

1.0

—

141.52

—

Phobic anxiety disorders

0.00

0.0

1.1

—

125.63

—

Ocular pain

0.00

0.0

1.1

—

118.12

—

Accidents

0.88

0.00

1.0

1.1

115.22

146.99

mmol/24h

—

Disorders of continuity of bone

0.00

0.0

1.1

—

115.46

—

Autoimmune hyperthyroidism

0.00

0.0

1.0

—

120.49

—

Otitis media, unspecified

0.00

0.0

1.6

—

132.29

—

Scleritis and episcleritis

0.00

0.0

1.2

—

123.01

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.0

—

122.62

—

Hypertensive heart and/or renal disease

0.00

0.0

1.0

—

145.24

—

Other benign neoplasms of connective and other soft tissue

0.00

0.0

1.0

—

129.93

—

Other respiratory disorders and diseases

0.00

0.0

1.0

—

134.75

—

Undetermined asthma, excluding more controls

0.00

0.0

1.0

—

137.30

—

Injury of muscle and tendon at wrist and hand level

0.00

0.0

1.1

—

135.31

—

Mental disorders, not otherwise specified

0.00

0.0

1.1

—

118.63

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.0

1.1

—

127.37

—

Injury of muscle and tendon at hip and thigh level

0.00

0.0

1.0

—

123.08

—

Superficial injury of hip and thigh

0.00

0.0

1.0

—

125.29

—

Injury of eye and orbit

0.00

0.0

1.1

—

122.31

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.0

1.1

—

104.24

—

Other osteochondropathies

0.00

0.0

1.2

—

133.41

—

Benign neoplasm: Rectum

0.00

0.0

1.0

—

128.23

—

Continuous positive airway pressure

0.00

0.0

1.0

—

143.43

—

Abnormal results of function studies

0.00

0.0

1.0

—

124.41

—

Gout, idiopatic and unspecified

0.00

0.0

1.0

—

139.63

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

1.0

—

133.49

—

Open wound of ankle and foot

0.00

0.0

1.0

—

133.49

—

Hypertensive diseases

0.86

0.00

1.0

1.1

127.72

135.24

mmol/24h

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.0

1.1

—

130.74

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

0.0

1.1

—

125.12

—

Ankylosing spondylitis

0.00

0.0

1.2

—

133.88

—

Tonsillectomy and adenotomy

0.89

0.00

1.2

1.1

147.68

137.09

mmol/24h

—

Hypertension

0.86

0.00

1.0

1.1

127.72

135.24

mmol/24h

—

Schizoaffective disorder

0.00

0.0

1.2

—

115.14

—

Benign leiomyoma with endometriosis

0.00

0.0

1.1

—

113.17

—

Disorders of gallbladder, biliary tract and pancreas

0.87

0.00

1.2

1.1

125.67

142.29

mmol/24h

—

Pneumonia, organism unspecified

0.98

0.00

1.2

1.1

147.92

148.57

mmol/24h

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

0.0

1.0

—

124.41

—

Benign neoplasm of eye and adnexa

0.00

0.0

1.0

—

129.93

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.0

1.0

—

122.62

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

1.0

—

118.89

—

Benign neoplasm of major salivary glands

0.00

0.0

1.0

—

129.93

—

Post-traumatic stress disorder

0.00

0.0

1.2

—

113.81

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

129.93

—

Seronegative rheumatoid arthritis

0.00

0.0

1.1

—

118.34

—

Mixed connective tissue disease

0.00

0.0

1.2

—

108.81

—

Other eating disorders

0.00

0.0

1.2

—

114.17

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

1.4

—

135.89

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.0

1.2

—

133.41

—

Fracture of femur

0.00

0.0

1.0

—

143.30

—

Dementia, including avohilmo

0.00

0.0

1.0

—

135.92

—

Other Crohn's disease

0.00

0.0

1.2

—

113.81

—

Viral warts

0.00

0.0

1.2

—

119.14

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.0

1.0

—

133.49

—

Other puerperal infections

0.00

0.0

1.1

—

111.72

—

Lichen sclerosus et atrophicus

0.00

0.0

1.0

—

124.41

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

0.0

1.0

—

121.42

—

Other and unspecified rosacea

0.00

0.0

1.1

—

118.34

—

Cholecystitis

0.00

0.0

1.0

—

124.41

—

Zoster [herpes zoster]

0.00

0.0

1.1

—

137.17

—

Herpesviral [herpes simplex] infections

0.00

0.0

1.1

—

123.18

—

Vitamin B12 deficiency anaemia

0.00

0.0

1.0

—

129.93

—

Seborrhoeic dermatitis

0.00

0.0

1.1

—

118.12

—

Congenital malformations of the circulatory system

0.00

0.0

1.1

—

123.18

—

Seborrhoeic keratosis

0.00

0.0

1.1

—

120.32

—

MS-disease / Multiple Sclerosis

0.00

0.0

1.1

—

122.36

—

Calcific tendinitis of shoulder

0.00

0.0

1.2

—

125.66

—

Lateral epicondylitis

0.00

0.0

1.1

—

130.51

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.0

—

134.75

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

129.93

—

Seropositive rheumatoid arthritis, strict definition

0.00

-0.00

0.0

1.1

—

118.34

—

Sequelae of infectious and parasitic diseases

0.00

-0.00

0.0

1.1

—

125.12

—

Parodontitis, under 40 years

0.00

-0.00

0.0

1.0

—

136.93

—

Ankylosing spondylitis, ICD10

0.00

-0.00

0.0

1.1

—

127.48

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sodium [Moles/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS